Advertisement

Influence of colchicine derivatives on lysosomal enzyme release from polymorphonuclear leukocytes and intracellular levels of cAMP after phagocytosis of monosodium urate crystals

  • Daniela Mikulíková
  • Karel Trnavský
Part of the Inflammation: Mechanisms and Treatment book series (FTIN, volume 4)

Abstract

Colchicine and its analogues belong to the group of microtubular inhibitors1. Microtubules are involved in the transport of extracellular material wrapped in vesicles towards lysosomes. Drug-induced tubulostasis may lead to reduced digestion of phagocytozed material and could prevent metabolic transformation of this material. These events possibly play a role in the inhibition of the generation of inflammatory mediators2. Colchicine does not stabilize isolated lysosomes3 and so its primary action on polymorphonuclear functions (release of lysosomal enzymes and chemotactic factors, motility etc.) is possibly mediated through its anti-microtubular activity4.

Keywords

Lysosomal Enzyme Enzyme Release Acute Gout Urate Crystal Calcium Pyrophosphate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brune, K. and Whitehouse, M. W. (1979). Cytostats with effects in chronic inflammation. In Vane, J. R. and Ferreira, S. H. (eds.) Anti-inflammatory Drugs, p. 531. (Berlin: Springer-Verlag).CrossRefGoogle Scholar
  2. 2.
    Wright, D. G. and Malawista, S. E. (1972). The mobilization and extracellular release of granular enzymes from human leukocytes during phagocytosis. J.Cell Biol., 53, 788PubMedCrossRefGoogle Scholar
  3. 3.
    Weissmann, G. (1966). Lysosomes and joint disease. Arthritis Rheum., 9, 834PubMedCrossRefGoogle Scholar
  4. 4.
    Fitzgerald, T.J. (1974). Colchicine and allopurinol. In Scherrer, R. A. and Whit-house, M. W. (eds.) Anti-inflammatory agents, Vol. 1, p. 295. (New York: Academic Press)Google Scholar
  5. 5.
    Wallace, S. L. (1959). Colchicine analogues in the treatment of gout. Arhritis Rheum., 2, 389CrossRefGoogle Scholar
  6. 6.
    Phelps, P. and McCarty, D. J. (1969). Crystal induced arthritis. Postgrad. Med., 45, 87PubMedGoogle Scholar
  7. 7.
    Fitzgerald, T. J., Williams, B. and Uyeki, E. M.(1971).Colchicineonsodiumurate-induced paw swelling in mice: Structure-activity relationships of colchicine derivatives. Proc. Soc. Exp. Biol. Med., 136, 115Google Scholar
  8. 8.
    McCarty, D.J. (1979). Short-term drug control of crystal-induced inflammation. In Vane, J. R. and Ferreira, S. H. (eds.) Anti-inflammatory Drugs, p. 92. (Berlin: Springer-Verlag)CrossRefGoogle Scholar
  9. 9.
    Zurier R. B., Hoffstein, S. and Weissmann, G. (1973). Mechanisms of lysosomal enzyme release from human leukocytes. J. Cell Biol., 58, 27PubMedCrossRefGoogle Scholar
  10. 10.
    Bergmeyer, H. U., Bernt, E. and Hees, B. (1965). Lactic dehydrogenase. In Bergmey-er, H. U. (ed.) Methods in Enzymatic Analysis, p. 736. (New York: Academic Press)Google Scholar
  11. 11.
    Ignarro, L. J. (1974). Nonphagocytic release of neutral protease and β-glucuronidase from human neutrophils. Arthritis Rheum., 17, 25PubMedCrossRefGoogle Scholar
  12. 12.
    Barrett, A. J. (1972). Lysosomal enzymes (Glycosidases). In Dingle, J. T. (ed.). Lysosomes — a Laboratory Handbook, p. 116. (Amsterdam: North-Holland Publishing Company).Google Scholar
  13. 13.
    Gilman, A. G. (1970). A protein binding assay for adenosine 3, 5-cyclic monophosphate. Proc. Natl. Acad. Sci. (USA), 67, 305CrossRefGoogle Scholar
  14. 14.
    Brown, B.L., Albano, J. D. M., Ekins, R. P. and Scherzi, A. M. (1971). A simple and sensitive saturation assay method for the measurement of adenosine 3′, 5′ -cyclic monophosphate. Biochem. J., 121, 561PubMedGoogle Scholar
  15. 15.
    Schumacher, H. R. and Phelps, P. (1971). Sequential changes in human PMN’s after urate crystal phagocytosis. Arthritis Rheum., 14, 513PubMedCrossRefGoogle Scholar
  16. 16.
    Weissmann, G. and Rita, G. (1972). Molecular basis of gouty inflammation: interaction of monosodium urate crystals with lysosomes and liposomes. Nature (London) New Biol., 240, 167CrossRefGoogle Scholar
  17. 17.
    Goldstein, I. M. (1976). Pharmacologic modulation of lysosomal enzyme release from polymorphonuclear leukocytes. J. Invest. Derm., 67, 622CrossRefGoogle Scholar
  18. 18.
    Malawista, S. E. (1968). Colchicine: a common mechanism for its anti-inflammatory and antimitotic effects. Arthritis Rheum., 11, 191PubMedCrossRefGoogle Scholar
  19. 19.
    Perper, R. J. and Oronsky, A. L. (1974). Enzyme release from human leukocytes and degradation of cartilage matrix: effects of antirheumatic drugs. Arthritis Rheum., 17, 47PubMedCrossRefGoogle Scholar
  20. 20.
    Wright, D. G. and Malawista, S. E. (1973). Mobilization and extracellular release of granular enzymes from human leukocytes during phagocytosis: inhibition by Cortisol and colchicine but not salicylates. Arthritis Rheum., 16, 749PubMedCrossRefGoogle Scholar
  21. 21.
    Pesanti, E. L. and Axline, S. G. (1975). Colchicine effects on lysosomal enzyme induction and intracellular degradation in the cultivated macrophage. J. Exp. Med., 141, 1030PubMedCrossRefGoogle Scholar
  22. 22.
    Andrews, R. and Phelps, P. (1971). Release of lysosomal enzymes from polymorphonuclear leukocytes after phagocytosis of monosodium urate and calcium pyrophosphate dihydrate crystals: Effect of colchicine and indomethacin. Arthritis Rheum., 14, 368Google Scholar
  23. 23.
    Rudolph, S. A., Greengard, P. and Malawista, S. E. (1977). Effects of colchicine on cyclic AMP levels in human leukocytes. Proc. Natl. Acad.Sci. (USA), 74, 3404CrossRefGoogle Scholar
  24. 24.
    Malawista, S. E., Oliver, J. M. and Rudolph, S. A. (1978). Microtubules and cyclic AMP in human leukocytes: on the order of things. J. Cell Biol., 77, 881PubMedCrossRefGoogle Scholar
  25. 25.
    Wallace, S. L. (1975). Colchicine and new anti-inflammatory drugs for the treatment of acute gout. Arthritis Rheum., 18, 847PubMedCrossRefGoogle Scholar
  26. 26.
    Mizel, S. B. and Wilson, L. (1972). Nucleoside transport in mammalian cells. Inhibition by colchicine. Biochemistry, 11, 2573PubMedCrossRefGoogle Scholar
  27. 27.
    Lettre, H. and Fernholz, H. (1943). Beitrag zur Beziehung zwischen der Mitosegiftwirkung und der Konstitution von Colchicine Derivativen. Z. Physiol. Chem., 278, 175CrossRefGoogle Scholar
  28. 28.
    Denko, C. W. and Whitehouse, M. W. (1970). Effects of colchicine in rats with uratecrystal-induced inflammation. Pharmacology, 3, 229PubMedCrossRefGoogle Scholar
  29. 29.
    Trnavsky, K. and Kopecky, S. (1966). The influence of some anti-inflammatory drugs on the inflammatory reaction to sodium urate. Med. Exp., 15, 322Google Scholar
  30. 30.
    Potëšilová et al. (1967). Collect. Czech. Chem. Commun., 32, 141Google Scholar

Copyright information

© MTP Press Limited 1980

Authors and Affiliations

  • Daniela Mikulíková
    • 1
  • Karel Trnavský
    • 1
  1. 1.Czechoslovakia

Personalised recommendations